{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:42:35Z","timestamp":1794627755989,"version":"4.9.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21145"],"award-info":[{"award-number":["CA21145"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["1649B032200498"],"award-info":[{"award-number":["1649B032200498"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijbiomac.2025.139630","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T11:16:48Z","timestamp":1736248608000},"page":"139630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exploring in vitro efficacy of rCHAPk with antibiotic combinations, and promising findings of its therapeutic potential for clinical-originated MRSA wound infection"],"prefix":"10.1016","volume":"296","author":[{"given":"Semra","family":"Tasdurmazli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Karamese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Aksak Karamese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Cadirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds D.R.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-7045","authenticated-orcid":false,"given":"Tulin","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.139630_bb0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14787210.2021.1858800","article-title":"Bacteriophages for ESKAPE: role in pathogenicity and measures of control","volume":"19","author":"Patil","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/antibiotics10121497","article-title":"Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application","volume":"10","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0015","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1073\/pnas.061038398","article-title":"Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme","volume":"98","author":"Nelson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/antibiotics7020029","article-title":"Engineering of phage-derived lytic enzymes: improving their potential as antimicrobials","volume":"7","author":"S\u00e3o-Jos\u00e9","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/fmb.12.97","article-title":"Bacteriophage endolysins as novel antimicrobials","volume":"7","author":"Schmelcher","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/v10040182","article-title":"Characterization of a new Staphylococcus aureus Kayvirus harboring a lysin active against biofilms","volume":"10","author":"Melo","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/v13040680","article-title":"The advantages and challenges of using endolysins in a clinical setting","volume":"13","author":"Murray","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0040","series-title":"Doi:10.2217\/Fmb.15.8","first-page":"377","article-title":"Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria","volume":"10","author":"Briers","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-13-7709-9_11","article-title":"Enzybiotics: enzyme-based antibacterials as therapeutics","volume":"1148","author":"Dams","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/v10060310","article-title":"Development of phage lysins as novel therapeutics: a historical perspective","volume":"10","author":"Fischetti","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126746","article-title":"Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents","volume":"248","author":"Grabowski","year":"2021","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmicb.2017.00293","article-title":"A novel antimicrobial endolysin, LysPA26, against Pseudomonas aeruginosa","volume":"8","author":"Guo","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2017","key":"10.1016\/j.ijbiomac.2025.139630_bb0065","first-page":"1","article-title":"A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus","volume":"7:1 7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bph.14106","article-title":"Phages of life \u2013 the path to pharma","volume":"175","author":"Forde","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0075","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/antibiotics10101143","article-title":"Current status of endolysin-based treatments against gram-negative bacteria","volume":"10","author":"Gontijo","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2012.10.011","article-title":"Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1","volume":"41","author":"Jun","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0085","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","article-title":"The recombinant phage Lysin LysK has a broad Spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus","volume":"187","author":"O\u2019Flaherty","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/AEM.01831-08","article-title":"Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci","volume":"75","author":"Horgan","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","article-title":"The truncated phage lysin CHAPk eliminates Staphylococcus aureus in the nares of mice","volume":"1","author":"Fenton","year":"2010","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/625341","article-title":"Bacteriophage-derived peptidase CHAPK eliminates and prevents staphylococcal biofilms","volume":"2013","author":"Fenton","year":"2013","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/microorganisms8020216","article-title":"Recombinant of the staphylococcal bacteriophage lysin CHAPk and its elimination against Streptococcus agalactiae biofilms","volume":"8","author":"Shan","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127969","article-title":"Expression and characterization of novel chimeric endolysin CHAPk-SH3bk against biofilm-forming methicillin-resistant Staphylococcus aureus","volume":"254","author":"Behera","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0115","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jid.2023.01.039","article-title":"Endolysin inhibits skin colonization by patient-derived staphylococcus aureus and malignant T-cell activation in cutaneous T-cell lymphoma","volume":"143","author":"Pallesen","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.01.018","article-title":"Selective depletion of Staphylococcus aureus restores the skin microbiome and accelerates tissue repair after injury","author":"Wilkinson","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0125","series-title":"Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model, Antimicrob Agents Chemother","volume":"vol. 63","author":"Bae","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.wndm.2020.100182","article-title":"Evaluation of bacteriophage products against burn wound Methicillin-resistant Staphylococcus aureus (MRSA) infections","volume":"28","author":"Rahimzadeh","year":"2020","journal-title":"Wound Med."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0135","author":"Heshmati"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/genomeA.01173-13","article-title":"Revised genome sequence of Staphylococcus aureus bacteriophage K","volume":"2","author":"Gill","year":"2014","journal-title":"Genome Announc."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-11-133","article-title":"Crystal structure of the lytic CHAPKdomain of the endolysin LysK from Staphylococcus aureus bacteriophage K","volume":"11","author":"Sanz-Gaitero","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0150","doi-asserted-by":"crossref","first-page":"2300145","DOI":"10.1002\/biot.202300145","article-title":"The evaluation of biotechnological potential of Gp144, the key molecule of natural predator bacteriophage K in Staphylococcus aureus hunting mechanism","author":"Tasdurmazli","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/femsle\/fnw216","article-title":"The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity","volume":"363","author":"Swift","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0160","doi-asserted-by":"crossref","DOI":"10.2174\/0929866528666210615104334","article-title":"In vitro evaluation of immunogenicity of recombinant OMP25 protein obtained from endemic Brucella abortus Biovar 3 as vaccine candidate molecule against animal brucellosis","volume":"28","author":"Atabey","year":"2021","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0165","author":"Lewis"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0170","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1088\/0957-4484\/27\/2\/025103","article-title":"Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods","volume":"27","author":"Arasoglu","year":"2015","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00731-18","article-title":"Effects of phage endolysin SAL200 combined with antibiotics on staphylococcus aureus infection","volume":"62","author":"Kim","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0180","author":"ASTM International"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-024-11898-3","article-title":"TIM-3\/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1","volume":"24","author":"Shapourian","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-023-04152-z","article-title":"Hesperetin attenuates the expression of markers of adipose tissue fibrosis in pre-adipocytes","volume":"23","author":"Taheri","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0195","series-title":"Cell Sensitivity Assays: The MTT Assay","first-page":"237","author":"van Meerloo","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ejphar.2017.11.011","article-title":"The role of urotensin-II and its receptors in sepsis-induced lung injury under diabetic conditions","volume":"818","author":"Ugan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12012-021-09698-3","article-title":"In vivo and in vitro cardioprotective effect of gossypin against isoproterenol-induced myocardial infarction injury","volume":"22","author":"Cinar","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.lfs.2019.02.039","article-title":"Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats","volume":"221","author":"Cinar","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0220","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/antibiotics10060722","article-title":"Engineering of the chapk staphylococcal phage endolysin to enhance antibacterial activity against stationary-phase cells","volume":"10","author":"Arroyo-Moreno","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0225","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2672.2011.05119.x","article-title":"Characterization of the staphylococcal bacteriophage lysin CHAPK","volume":"111","author":"Fenton","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb5000","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/antibiotics10020124","article-title":"Phage-Encoded Endolysins","volume":"10","author":"Abdelrahman","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/B978-0-12-394438-2.00007-4","article-title":"Endolysins as antimicrobials","volume":"83","author":"Nelson","year":"2012","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/9781683670438.CMPH","article-title":"Synergism testing: broth microdilution checkerboard and broth macrodilution methods","volume":"5.16.1-5.16.23","author":"Leber","year":"2016","journal-title":"Clin. Microbiol. Proc. Handb."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0240","article-title":"A novel chimeric endolysin with antibacterial activity against methicillin-resistant Staphylococcus aureus","volume":"7","author":"Kashani","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0245","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.01625-09","article-title":"Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus","volume":"54","author":"Daniel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02252","article-title":"Phage lysins for fighting bacterial respiratory infections: a new generation of antimicrobials","volume":"9","author":"V\u00e1zquez","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0255","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.02526-12","article-title":"Novel bacteriophage lysin with broad lytic activity protects against mixed infection by streptococcus pyogenes and methicillin-resistant staphylococcus aureus","volume":"57","author":"Gilmer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0260","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tim.2005.08.007","article-title":"Bacteriophage lytic enzymes: novel anti-infectives","volume":"13","author":"Fischetti","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0265","article-title":"Inflammatory microenvironment of skin wounds","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0270","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of phages and antibiotics: two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0275","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2217\/fmb-2018-0077","article-title":"Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus","volume":"13","author":"Letrado","year":"2018","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cben.201600002","article-title":"Production and purification of recombinant proteins from Escherichia coli","volume":"3","author":"Tripathi","year":"2016","journal-title":"ChemBioEng Rev."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0285","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1038\/s41598-021-99875-9","article-title":"Long-term stability predictions of therapeutic monoclonal antibodies in solution using Arrhenius-based kinetics","volume":"11","author":"Kuzman","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0290","first-page":"1","article-title":"In vivo stability of therapeutic proteins","volume":"2020 37:2 37","author":"Schuster","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0295","first-page":"149","article-title":"Stability enhancement of \u03b1-amylase by supercritical carbon dioxide pretreatment","volume":"16","author":"Liu","year":"2000","journal-title":"Prog. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0305","series-title":"L929 Cell Cytotoxicity Associated with Experimental and Commercial Dental Flosses","author":"Tua-Ngam","year":"2017"},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3469525","article-title":"Cytotoxicity evaluation of endodontic pins on L929 cell line","volume":"2019","author":"Cannella","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00380-18","article-title":"A phage Lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant Staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice","volume":"84","author":"Wang","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0320","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02273-21","article-title":"Linker-improved chimeric endolysin selectively kills Staphylococcus aureus in vitro, on reconstituted human epidermis, and in a murine model of skin infection","volume":"66","author":"Eichenseher","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0325","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijmm.2016.08.003","article-title":"Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice","volume":"306","author":"Chopra","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0330","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pro.589","article-title":"Structure and mechanism of Escherichia coli glutathionylspermidine amidase belonging to the family of cysteine; histidine-dependent amidohydrolases\/peptidases","volume":"20","author":"Pai","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0335","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.5152\/eurasianjmed.2022.22303","article-title":"A new target in inflammatory diseases: lycopene","volume":"54","author":"Karak\u00f6y","year":"2022","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0340","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1177\/147323000903700531","article-title":"The wound healing process: an overview of the cellular and molecular mechanisms","volume":"37","author":"Velnar","year":"2009","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ijbiomac.2025.139630_bb0345","first-page":"231","article-title":"Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23","volume":"19","author":"B\u00e4uerl","year":"2010","journal-title":"J. Mol. Microbiol. Biotechnol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:01:00Z","timestamp":1786395660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":70,"alternative-id":["S0141813025001795"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139630","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring in vitro efficacy of rCHAPk with antibiotic combinations, and promising findings of its therapeutic potential for clinical-originated MRSA wound infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139630"}}